Transapical transcatheter mitral valve implantation with J-valve in patients with degenerated mitral bioprostheses

BMC Cardiovascular Disorders

Case Report

Fan He¹  Shiqiang Wang¹  Jianmao Hong¹  Bijun Xu¹  Huaidong Chen¹  Ximing Qian¹ 

[1] Department of Cardiovascular Surgery, Sir Run Run Shaw Hospital, Zhejiang University, East Qingchun Road 3th, 310020, Hangzhou, Zhejiang, China;

关键词: J-valve;    Transcatheter mitral valve implantation;    Valve-in-valve;    Transapical;   

DOI  :  10.1186/s12872-023-03414-5

 received in 2023-05-11, accepted in 2023-07-24,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundDue to the widespread application of bioprosthetic valve in the treatment of mitral valve disease in recent years, the incidence of valve failure has increased significantly, which is facing the need of reoperation. For high-risk patients, transcatheter mitral valve-in-valve placement is increasingly being used as an alternative to surgical reoperation.Case presentationHere we report the successful transapical transcatheter mitral valve-in-valve implantations of J-Valves in 3 patients with high risk of mitral bioprostheses failure. All patients were discharged successfully, and the follow-up results were good 30 days after operation without major complication.ConclusionsFor high-risk patients, transcatheter implantation of the J-valve is a feasible solution for the treatment of degenerated mitral bioprostheses.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 图 表 】

12862_2023_2133_Article_IEq10.gif

Fig. 1

Fig. 2